Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
6.08
+0.05 (0.83%)
Nov 21, 2024, 2:43 PM EST - Market open
Coya Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 93 | 107 | 12 | - | - |
| Market Cap Growth | 157.01% | 769.50% | - | - | - |
| Enterprise Value | 61 | 96 | 24 | - | - |
| Last Close Price | 6.03 | 7.41 | 4.74 | - | - |
| PS Ratio | 8.78 | 17.78 | - | - | - |
| PB Ratio | 2.87 | 2.99 | -1.46 | - | - |
| P/TBV Ratio | 3.07 | 2.99 | - | - | - |
| EV/Sales Ratio | 6.36 | 15.96 | - | - | - |
| Debt / Equity Ratio | - | - | -1.54 | - | - |
| Asset Turnover | 0.40 | 0.24 | - | - | - |
| Quick Ratio | 13.39 | 7.94 | 1.55 | 3.78 | 19.51 |
| Current Ratio | 15.31 | 8.15 | 1.88 | 3.99 | 19.57 |
| Return on Equity (ROE) | -50.83% | -58.64% | - | -81.90% | - |
| Return on Assets (ROA) | -29.34% | -18.53% | -88.03% | -44.96% | - |
| Return on Capital (ROIC) | -33.07% | -22.88% | -141.30% | -50.96% | - |
| Earnings Yield | -11.66% | -7.49% | -99.77% | - | - |
| FCF Yield | -11.03% | -10.49% | -58.99% | - | - |
| Buyback Yield / Dilution | -72.72% | -292.40% | -0.01% | -40.88% | - |
| Total Shareholder Return | -72.72% | -292.40% | -0.01% | -40.88% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.